Conagra Brands vs Campbell'S
CAG and CPB side by side, both in food and kindred products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CAG and CPB compare
Conagra Brands and Campbell'S are about the same size, with market caps of $7.0B and $6.4B.
Conagra Brands grew revenue faster over the last twelve months (−1.8% versus −5.0% for Campbell'S).
Campbell'S keeps more of each dollar of sales as profit, with a net margin of 4.1% compared with −17.0% at Conagra Brands.
Both pay dividends: Conagra Brands yields 6.0% and Campbell'S 6.6%.
Campbell'S scores higher on the StockData Score (13 against 10 for Conagra Brands), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CAG | CPB |
|---|---|---|
| Size and price | ||
| Market cap | $7.0B | $6.4B |
| Share price | $14.57 | $21.42 |
| Change, 1 year | −16.2% | −28.6% |
| Change, 5 years | −55.3% | −47.4% |
| Beta (5Y) | 0.15 | 0.11 |
| Employees | 17K | 14K |
| StockData Score | ||
| Total score | 10 | 13 (better) |
| Valuation score | 2 | 6 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 0 | 2 (better) |
| Health score | 2 (better) | 0 |
| Dividend score | 5 | 5 |
| Valuation | ||
| P/E | – | 16.4× |
| P/S | 0.6× (better) | 0.7× |
| P/B | – | 1.7× |
| EV/EBITDA | – | 10.4× |
| P/FCF | 7.9× (better) | 9.4× |
| FCF yield | 12.6% (better) | 10.6% |
| Fair value | $30.34 | $28.53 |
| Margin of safety | 52.0% (better) | 24.9% |
| Growth | ||
| Revenue growth (TTM) | −1.8% (better) | −5.0% |
| Revenue growth, 5Y average | 0.17% | 2.8% (better) |
| Net income growth (TTM) | −324% | −33.1% (better) |
| EPS growth (TTM) | −326% | −34.8% (better) |
| EPS growth, 5Y average | – | −16.8% |
| Profitability | ||
| Gross margin | 23.8% | 28.1% (better) |
| Operating margin | −15.2% | 8.7% (better) |
| Net margin | −17.0% | 4.1% (better) |
| FCF margin | 7.8% (better) | 7.0% |
| Return on equity | – | 10.4% |
| Return on invested capital | – | 6.1% |
| Financial health | ||
| Debt / equity | – | 1.85 |
| Net debt / EBITDA | – | 5.33 |
| Interest coverage | – | 2.6× |
| Current ratio | 1.10 (better) | 0.82 |
| Altman Z-score | 1.04 | 1.50 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 6.0% | 6.6% (better) |
| Payout ratio | – | 117% |
| Years of dividend growth | 0 | 2 (better) |
| Dividend growth, 5Y average | 6.2% (better) | 1.3% |
| Buyback yield | 0.64% (better) | 0.41% |
| Shareholder yield | 6.6% | 7.0% (better) |
| Ownership | ||
| Held by institutions | 88.9% | 62.1% |
| Held by insiders | 0.78% | 38.5% |
| Insider net buying, 12 months | $896K (better) | −$390K |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 8.3% | 19.5% |
Go deeper
- CAG stock overview
- CAG income statement
- CAG valuation and score
- CPB stock overview
- CPB income statement
- CPB valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.